Edap Tms (NASDAQ:EDAP) & CONMED (NYSE:CNMD) Head-To-Head Comparison

Edap Tms (NASDAQ:EDAP) and CONMED (NYSE:CNMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Risk & Volatility

Edap Tms has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Profitability

This table compares Edap Tms and CONMED’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Edap Tms	-34.92%	-44.21%	-25.88%
CONMED	10.13%	14.60%	5.64%

Earnings and Valuation

This table compares Edap Tms and CONMED”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$65.42 million	1.42	-$22.92 million	($0.65)	-3.85
CONMED	$1.31 billion	1.59	$64.46 million	$4.24	15.90

CONMED has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Edap Tms and CONMED, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	0	0	1	0	3.00
CONMED	0	2	3	0	2.60

Edap Tms presently has a consensus target price of $19.00, suggesting a potential upside of 660.00%. CONMED has a consensus target price of $77.20, suggesting a potential upside of 14.53%. Given Edap Tms’ stronger consensus rating and higher probable upside, research analysts clearly believe Edap Tms is more favorable than CONMED.

Institutional and Insider Ownership

62.7% of Edap Tms shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Comparatively, 6.8% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

CONMED beats Edap Tms on 11 of the 14 factors compared between the two stocks.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.